Novartis AG (NVSEF) stock
NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS
$146.46+2.56 (+1.78%)
Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –
Novartis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Novartis's enterprise value was $304.14B on Nov 3, 2026, against $258.78B a year earlier. Over the last 5 years it ranged from $168.24B to $312.21B, with a median of $212.80B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 3, 2026 | $304.14B | +11.0% |
| 2025 | Dec 31, 2025 | $273.98B | +39.9% |
| 2024 | Dec 31, 2024 | $195.84B | -7.2% |
| 2023 | Dec 29, 2023 | $211.03B | +4.7% |
| 2022 | Dec 30, 2022 | $201.48B | +2.9% |
| 2021 | Dec 31, 2021 | $195.80B | -8.1% |
| 2020 | Dec 31, 2020 | $213.14B | +0.5% |
| 2019 | Dec 31, 2019 | $212.04B | +13.5% |
| 2018 | Dec 31, 2018 | $186.87B | -3.4% |
| 2017 | Dec 29, 2017 | $193.40B | +15.0% |
| 2016 | Dec 30, 2016 | $168.24B | -13.0% |
| 2015 | Dec 31, 2015 | $193.35B | – |
See a number that looks wrong?